Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions: evidence from an international multi-centre study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions : evidence from an international multi-centre study. / Ponti, Antonio; Ronco, Guglielmo; Lynge, Elsebeth; Tomatis, Mariano; Anttila, Ahti; Ascunce, Nieves; Broeders, Mireille; Bulliard, Jean-Luc; Castellano, Isabella; Fitzpatrick, Patricia; Frigerio, Alfonso; Hofvind, Solveig; Majek, Ondrej; Segnan, Nereo; Taplin, Stephen.

In: Breast Cancer Research and Treatment, Vol. 177, No. 3, 2019, p. 761-765.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Ponti, A, Ronco, G, Lynge, E, Tomatis, M, Anttila, A, Ascunce, N, Broeders, M, Bulliard, J-L, Castellano, I, Fitzpatrick, P, Frigerio, A, Hofvind, S, Majek, O, Segnan, N & Taplin, S 2019, 'Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions: evidence from an international multi-centre study', Breast Cancer Research and Treatment, vol. 177, no. 3, pp. 761-765. https://doi.org/10.1007/s10549-019-05333-6

APA

Ponti, A., Ronco, G., Lynge, E., Tomatis, M., Anttila, A., Ascunce, N., ... Taplin, S. (2019). Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions: evidence from an international multi-centre study. Breast Cancer Research and Treatment, 177(3), 761-765. https://doi.org/10.1007/s10549-019-05333-6

Vancouver

Ponti A, Ronco G, Lynge E, Tomatis M, Anttila A, Ascunce N et al. Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions: evidence from an international multi-centre study. Breast Cancer Research and Treatment. 2019;177(3):761-765. https://doi.org/10.1007/s10549-019-05333-6

Author

Ponti, Antonio ; Ronco, Guglielmo ; Lynge, Elsebeth ; Tomatis, Mariano ; Anttila, Ahti ; Ascunce, Nieves ; Broeders, Mireille ; Bulliard, Jean-Luc ; Castellano, Isabella ; Fitzpatrick, Patricia ; Frigerio, Alfonso ; Hofvind, Solveig ; Majek, Ondrej ; Segnan, Nereo ; Taplin, Stephen. / Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions : evidence from an international multi-centre study. In: Breast Cancer Research and Treatment. 2019 ; Vol. 177, No. 3. pp. 761-765.

Bibtex

@article{f63f1dd02be840ebb2ccb5ca5627a93d,
title = "Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions: evidence from an international multi-centre study",
keywords = "Breast cancer screening, Ductal carcinoma in situ, Low-grade DCIS, Overtreatment",
author = "Antonio Ponti and Guglielmo Ronco and Elsebeth Lynge and Mariano Tomatis and Ahti Anttila and Nieves Ascunce and Mireille Broeders and Jean-Luc Bulliard and Isabella Castellano and Patricia Fitzpatrick and Alfonso Frigerio and Solveig Hofvind and Ondrej Majek and Nereo Segnan and Stephen Taplin",
year = "2019",
doi = "10.1007/s10549-019-05333-6",
language = "English",
volume = "177",
pages = "761--765",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer",
number = "3",

}

RIS

TY - JOUR

T1 - Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions

T2 - evidence from an international multi-centre study

AU - Ponti, Antonio

AU - Ronco, Guglielmo

AU - Lynge, Elsebeth

AU - Tomatis, Mariano

AU - Anttila, Ahti

AU - Ascunce, Nieves

AU - Broeders, Mireille

AU - Bulliard, Jean-Luc

AU - Castellano, Isabella

AU - Fitzpatrick, Patricia

AU - Frigerio, Alfonso

AU - Hofvind, Solveig

AU - Majek, Ondrej

AU - Segnan, Nereo

AU - Taplin, Stephen

PY - 2019

Y1 - 2019

KW - Breast cancer screening

KW - Ductal carcinoma in situ

KW - Low-grade DCIS

KW - Overtreatment

U2 - 10.1007/s10549-019-05333-6

DO - 10.1007/s10549-019-05333-6

M3 - Journal article

C2 - 31250357

VL - 177

SP - 761

EP - 765

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -

ID: 228152386